1. Home
  2. SRPT vs NVT Comparison

SRPT vs NVT Comparison

Compare SRPT & NVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • NVT
  • Stock Information
  • Founded
  • SRPT 1980
  • NVT 1903
  • Country
  • SRPT United States
  • NVT United Kingdom
  • Employees
  • SRPT N/A
  • NVT N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • NVT Industrial Machinery/Components
  • Sector
  • SRPT Health Care
  • NVT Industrials
  • Exchange
  • SRPT Nasdaq
  • NVT Nasdaq
  • Market Cap
  • SRPT 9.8B
  • NVT 11.1B
  • IPO Year
  • SRPT 1997
  • NVT N/A
  • Fundamental
  • Price
  • SRPT $53.79
  • NVT $49.84
  • Analyst Decision
  • SRPT Buy
  • NVT Strong Buy
  • Analyst Count
  • SRPT 22
  • NVT 8
  • Target Price
  • SRPT $156.77
  • NVT $70.38
  • AVG Volume (30 Days)
  • SRPT 2.8M
  • NVT 2.5M
  • Earning Date
  • SRPT 04-30-2025
  • NVT 05-02-2025
  • Dividend Yield
  • SRPT N/A
  • NVT 1.60%
  • EPS Growth
  • SRPT N/A
  • NVT N/A
  • EPS
  • SRPT 2.34
  • NVT 1.97
  • Revenue
  • SRPT $1,901,979,000.00
  • NVT $3,006,100,000.00
  • Revenue This Year
  • SRPT $66.51
  • NVT $9.41
  • Revenue Next Year
  • SRPT $21.66
  • NVT $5.53
  • P/E Ratio
  • SRPT $23.00
  • NVT $34.85
  • Revenue Growth
  • SRPT 52.97
  • NVT 12.63
  • 52 Week Low
  • SRPT $48.01
  • NVT $41.71
  • 52 Week High
  • SRPT $173.25
  • NVT $86.57
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 31.45
  • NVT 42.99
  • Support Level
  • SRPT $53.02
  • NVT $48.78
  • Resistance Level
  • SRPT $56.34
  • NVT $51.36
  • Average True Range (ATR)
  • SRPT 4.23
  • NVT 3.29
  • MACD
  • SRPT 1.05
  • NVT 0.33
  • Stochastic Oscillator
  • SRPT 29.70
  • NVT 60.91

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About NVT nVent Electric plc

nVent is a leading global provider of electrical connection and protection solutions that touches a broad range of end markets including infrastructure, industrial, commercial, and residential. NVent designs, manufacturers, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.

Share on Social Networks: